Getinge (OTCMKTS:GNGBY – Get Free Report)’s share price hit a new 52-week high during trading on Thursday . The stock traded as high as $24.67 and last traded at $24.67, with a volume of 167 shares traded. The stock had previously closed at $24.25.
Analysts Set New Price Targets
Separately, Zacks Research upgraded Getinge from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. Based on data from MarketBeat.com, Getinge presently has an average rating of “Strong Buy”.
Read Our Latest Stock Analysis on GNGBY
Getinge Stock Up 0.4%
Getinge (OTCMKTS:GNGBY – Get Free Report) last announced its quarterly earnings data on Friday, July 17th. The company reported $0.38 EPS for the quarter. The firm had revenue of $894.87 million for the quarter. Getinge had a net margin of 7.81% and a return on equity of 11.12%. As a group, equities research analysts predict that Getinge will post 1.38 EPS for the current fiscal year.
Getinge Company Profile
Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.
The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.
Recommended Stories
- Five stocks we like better than Getinge
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.
